Brisbane-based Freenome has locked in a second major partnership for its blood-based cancer screening test, this time with a ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

Colorectal cancer is the second leading cause of cancer-related deaths in the US, despite a high survival rate when detected ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

A recent UCLA study revealed that fewer than one in four eligible adults aged 45-49 underwent colorectal cancer screening ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Gretchen Carlson Spills Why Trump's 'Piggy' ...

Worldwide, colorectal cancer is the second leading cause of cancer-related mortality and the third most common cancer, with incidence rates increasing among individuals younger than 50 years.1 ...

Among 997 patients with lung cancer, only 35.1% met USPSTF screening criteria, while universal age-based screening (40-85 ...

More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...